nodes	percent_of_prediction	percent_of_DWPC	metapath
Prasugrel—ALB—Vismodegib—skin cancer	0.166	0.197	CbGbCtD
Prasugrel—ALB—Vemurafenib—skin cancer	0.131	0.156	CbGbCtD
Prasugrel—CYP2C19—Vismodegib—skin cancer	0.108	0.128	CbGbCtD
Prasugrel—CYP2C9—Vismodegib—skin cancer	0.0895	0.106	CbGbCtD
Prasugrel—CYP3A4—Imiquimod—skin cancer	0.0751	0.0891	CbGbCtD
Prasugrel—CYP3A4—Temozolomide—skin cancer	0.0751	0.0891	CbGbCtD
Prasugrel—ALB—Fluorouracil—skin cancer	0.059	0.07	CbGbCtD
Prasugrel—CYP3A4—Vismodegib—skin cancer	0.052	0.0618	CbGbCtD
Prasugrel—CYP3A4—Vemurafenib—skin cancer	0.0411	0.0488	CbGbCtD
Prasugrel—CYP2C9—Fluorouracil—skin cancer	0.0318	0.0377	CbGbCtD
Prasugrel—CYP3A4—Docetaxel—skin cancer	0.0141	0.0168	CbGbCtD
Prasugrel—Non-cardiac chest pain—Docetaxel—skin cancer	0.00584	0.0371	CcSEcCtD
Prasugrel—Neoplasm malignant—Vismodegib—skin cancer	0.00565	0.0359	CcSEcCtD
Prasugrel—Haemorrhage intracranial—Temozolomide—skin cancer	0.00372	0.0236	CcSEcCtD
Prasugrel—Pain in extremity—Vismodegib—skin cancer	0.0035	0.0223	CcSEcCtD
Prasugrel—Neoplasm malignant—Vemurafenib—skin cancer	0.00349	0.0222	CcSEcCtD
Prasugrel—Neoplasm—Vemurafenib—skin cancer	0.0027	0.0171	CcSEcCtD
Prasugrel—Hypercholesterolaemia—Imiquimod—skin cancer	0.00269	0.0171	CcSEcCtD
Prasugrel—Pericardial effusion—Docetaxel—skin cancer	0.00247	0.0157	CcSEcCtD
Prasugrel—Atrial fibrillation—Vemurafenib—skin cancer	0.00228	0.0145	CcSEcCtD
Prasugrel—Pain in extremity—Vemurafenib—skin cancer	0.00216	0.0138	CcSEcCtD
Prasugrel—Back pain—Vismodegib—skin cancer	0.00204	0.013	CcSEcCtD
Prasugrel—Atrial fibrillation—Imiquimod—skin cancer	0.00195	0.0124	CcSEcCtD
Prasugrel—Cerebrovascular accident—Imiquimod—skin cancer	0.00188	0.012	CcSEcCtD
Prasugrel—Pain in extremity—Imiquimod—skin cancer	0.00185	0.0117	CcSEcCtD
Prasugrel—Unspecified disorder of skin and subcutaneous tissue—Vismodegib—skin cancer	0.00178	0.0113	CcSEcCtD
Prasugrel—Skin disorder—Vismodegib—skin cancer	0.00167	0.0106	CcSEcCtD
Prasugrel—Gastrointestinal disorder—Vismodegib—skin cancer	0.00149	0.00945	CcSEcCtD
Prasugrel—Fatigue—Vismodegib—skin cancer	0.00148	0.00944	CcSEcCtD
Prasugrel—Oedema peripheral—Vemurafenib—skin cancer	0.00148	0.00938	CcSEcCtD
Prasugrel—Eye disorder—Vemurafenib—skin cancer	0.0014	0.0089	CcSEcCtD
Prasugrel—Neoplasm—Temozolomide—skin cancer	0.00138	0.00876	CcSEcCtD
Prasugrel—Angiopathy—Vemurafenib—skin cancer	0.00136	0.00864	CcSEcCtD
Prasugrel—Mediastinal disorder—Vemurafenib—skin cancer	0.00135	0.00858	CcSEcCtD
Prasugrel—Cerebrovascular accident—Bleomycin—skin cancer	0.00134	0.00851	CcSEcCtD
Prasugrel—Haemoglobin—Imiquimod—skin cancer	0.00128	0.00816	CcSEcCtD
Prasugrel—Haemorrhage—Imiquimod—skin cancer	0.00128	0.00812	CcSEcCtD
Prasugrel—Urinary tract disorder—Imiquimod—skin cancer	0.00126	0.00802	CcSEcCtD
Prasugrel—Back pain—Vemurafenib—skin cancer	0.00126	0.00802	CcSEcCtD
Prasugrel—Urethral disorder—Imiquimod—skin cancer	0.00125	0.00796	CcSEcCtD
Prasugrel—Asthenia—Vismodegib—skin cancer	0.00124	0.00785	CcSEcCtD
Prasugrel—Eye disorder—Imiquimod—skin cancer	0.00119	0.00759	CcSEcCtD
Prasugrel—Diarrhoea—Vismodegib—skin cancer	0.00118	0.00749	CcSEcCtD
Prasugrel—Angiopathy—Imiquimod—skin cancer	0.00116	0.00737	CcSEcCtD
Prasugrel—Immune system disorder—Imiquimod—skin cancer	0.00115	0.00733	CcSEcCtD
Prasugrel—Mediastinal disorder—Imiquimod—skin cancer	0.00115	0.00732	CcSEcCtD
Prasugrel—Cough—Vemurafenib—skin cancer	0.00114	0.00723	CcSEcCtD
Prasugrel—Unspecified disorder of skin and subcutaneous tissue—Vemurafenib—skin cancer	0.0011	0.00701	CcSEcCtD
Prasugrel—Rash—Vismodegib—skin cancer	0.00109	0.0069	CcSEcCtD
Prasugrel—Dermatitis—Vismodegib—skin cancer	0.00108	0.0069	CcSEcCtD
Prasugrel—Back pain—Imiquimod—skin cancer	0.00108	0.00684	CcSEcCtD
Prasugrel—Anaphylactic shock—Vemurafenib—skin cancer	0.00106	0.00676	CcSEcCtD
Prasugrel—Skin disorder—Vemurafenib—skin cancer	0.00103	0.00657	CcSEcCtD
Prasugrel—Nausea—Vismodegib—skin cancer	0.00102	0.0065	CcSEcCtD
Prasugrel—Gastrointestinal haemorrhage—Fluorouracil—skin cancer	0.00102	0.00648	CcSEcCtD
Prasugrel—Angioedema—Imiquimod—skin cancer	0.00102	0.00646	CcSEcCtD
Prasugrel—Hypotension—Vemurafenib—skin cancer	0.000994	0.00632	CcSEcCtD
Prasugrel—Cough—Imiquimod—skin cancer	0.00097	0.00617	CcSEcCtD
Prasugrel—Haematuria—Bleomycin—skin cancer	0.000964	0.00613	CcSEcCtD
Prasugrel—Hypertension—Imiquimod—skin cancer	0.00096	0.0061	CcSEcCtD
Prasugrel—Unspecified disorder of skin and subcutaneous tissue—Imiquimod—skin cancer	0.00094	0.00598	CcSEcCtD
Prasugrel—Gastrointestinal disorder—Vemurafenib—skin cancer	0.000919	0.00584	CcSEcCtD
Prasugrel—Fatigue—Vemurafenib—skin cancer	0.000917	0.00583	CcSEcCtD
Prasugrel—Neoplasm—Docetaxel—skin cancer	0.000916	0.00582	CcSEcCtD
Prasugrel—Haemoglobin—Bleomycin—skin cancer	0.000912	0.0058	CcSEcCtD
Prasugrel—Haemorrhage—Bleomycin—skin cancer	0.000907	0.00577	CcSEcCtD
Prasugrel—Skin disorder—Imiquimod—skin cancer	0.000881	0.0056	CcSEcCtD
Prasugrel—Body temperature increased—Vemurafenib—skin cancer	0.000841	0.00535	CcSEcCtD
Prasugrel—Dyspnoea—Imiquimod—skin cancer	0.000809	0.00514	CcSEcCtD
Prasugrel—Hypersensitivity—Vemurafenib—skin cancer	0.000784	0.00498	CcSEcCtD
Prasugrel—Gastrointestinal disorder—Imiquimod—skin cancer	0.000783	0.00498	CcSEcCtD
Prasugrel—Fatigue—Imiquimod—skin cancer	0.000782	0.00497	CcSEcCtD
Prasugrel—Atrial fibrillation—Docetaxel—skin cancer	0.000776	0.00494	CcSEcCtD
Prasugrel—Haemoglobin—Temozolomide—skin cancer	0.000769	0.00489	CcSEcCtD
Prasugrel—Haemorrhage—Temozolomide—skin cancer	0.000765	0.00487	CcSEcCtD
Prasugrel—Asthenia—Vemurafenib—skin cancer	0.000763	0.00485	CcSEcCtD
Prasugrel—Urinary tract disorder—Temozolomide—skin cancer	0.000756	0.0048	CcSEcCtD
Prasugrel—Oedema peripheral—Temozolomide—skin cancer	0.000754	0.00479	CcSEcCtD
Prasugrel—Urethral disorder—Temozolomide—skin cancer	0.00075	0.00477	CcSEcCtD
Prasugrel—Epistaxis—Fluorouracil—skin cancer	0.000741	0.00471	CcSEcCtD
Prasugrel—Pain in extremity—Docetaxel—skin cancer	0.000736	0.00468	CcSEcCtD
Prasugrel—Gastrointestinal haemorrhage—Docetaxel—skin cancer	0.000736	0.00468	CcSEcCtD
Prasugrel—Anaemia—Bleomycin—skin cancer	0.00073	0.00464	CcSEcCtD
Prasugrel—Diarrhoea—Vemurafenib—skin cancer	0.000728	0.00463	CcSEcCtD
Prasugrel—Body temperature increased—Imiquimod—skin cancer	0.000717	0.00456	CcSEcCtD
Prasugrel—Eye disorder—Temozolomide—skin cancer	0.000715	0.00455	CcSEcCtD
Prasugrel—Haemoglobin—Fluorouracil—skin cancer	0.000709	0.00451	CcSEcCtD
Prasugrel—Leukopenia—Bleomycin—skin cancer	0.000707	0.00449	CcSEcCtD
Prasugrel—Haemorrhage—Fluorouracil—skin cancer	0.000705	0.00448	CcSEcCtD
Prasugrel—Dizziness—Vemurafenib—skin cancer	0.000704	0.00447	CcSEcCtD
Prasugrel—Angiopathy—Temozolomide—skin cancer	0.000694	0.00441	CcSEcCtD
Prasugrel—Immune system disorder—Temozolomide—skin cancer	0.000691	0.00439	CcSEcCtD
Prasugrel—Mediastinal disorder—Temozolomide—skin cancer	0.00069	0.00438	CcSEcCtD
Prasugrel—Cough—Bleomycin—skin cancer	0.000689	0.00438	CcSEcCtD
Prasugrel—Anaemia—Dactinomycin—skin cancer	0.000681	0.00433	CcSEcCtD
Prasugrel—Rash—Vemurafenib—skin cancer	0.000671	0.00426	CcSEcCtD
Prasugrel—Dermatitis—Vemurafenib—skin cancer	0.00067	0.00426	CcSEcCtD
Prasugrel—Hypersensitivity—Imiquimod—skin cancer	0.000669	0.00425	CcSEcCtD
Prasugrel—Headache—Vemurafenib—skin cancer	0.000667	0.00424	CcSEcCtD
Prasugrel—Leukopenia—Dactinomycin—skin cancer	0.000659	0.00419	CcSEcCtD
Prasugrel—Asthenia—Imiquimod—skin cancer	0.000651	0.00414	CcSEcCtD
Prasugrel—Anaphylactic shock—Bleomycin—skin cancer	0.000645	0.0041	CcSEcCtD
Prasugrel—Back pain—Temozolomide—skin cancer	0.000644	0.0041	CcSEcCtD
Prasugrel—Nausea—Vemurafenib—skin cancer	0.000632	0.00402	CcSEcCtD
Prasugrel—Thrombocytopenia—Bleomycin—skin cancer	0.000631	0.00401	CcSEcCtD
Prasugrel—Diarrhoea—Imiquimod—skin cancer	0.000621	0.00395	CcSEcCtD
Prasugrel—Anaemia—Temozolomide—skin cancer	0.000616	0.00391	CcSEcCtD
Prasugrel—Angioedema—Temozolomide—skin cancer	0.000609	0.00387	CcSEcCtD
Prasugrel—Hypotension—Bleomycin—skin cancer	0.000602	0.00383	CcSEcCtD
Prasugrel—Dizziness—Imiquimod—skin cancer	0.0006	0.00381	CcSEcCtD
Prasugrel—Leukopenia—Temozolomide—skin cancer	0.000596	0.00379	CcSEcCtD
Prasugrel—Thrombocytopenia—Dactinomycin—skin cancer	0.000589	0.00374	CcSEcCtD
Prasugrel—Cough—Temozolomide—skin cancer	0.000581	0.0037	CcSEcCtD
Prasugrel—Hypertension—Temozolomide—skin cancer	0.000575	0.00366	CcSEcCtD
Prasugrel—Dyspnoea—Bleomycin—skin cancer	0.000575	0.00365	CcSEcCtD
Prasugrel—Rash—Imiquimod—skin cancer	0.000572	0.00364	CcSEcCtD
Prasugrel—Dermatitis—Imiquimod—skin cancer	0.000572	0.00363	CcSEcCtD
Prasugrel—Headache—Imiquimod—skin cancer	0.000568	0.00361	CcSEcCtD
Prasugrel—Anaemia—Fluorouracil—skin cancer	0.000567	0.00361	CcSEcCtD
Prasugrel—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—skin cancer	0.000563	0.00358	CcSEcCtD
Prasugrel—Leukopenia—Fluorouracil—skin cancer	0.00055	0.00349	CcSEcCtD
Prasugrel—Anaphylactic shock—Temozolomide—skin cancer	0.000544	0.00346	CcSEcCtD
Prasugrel—Nausea—Imiquimod—skin cancer	0.000539	0.00343	CcSEcCtD
Prasugrel—Epistaxis—Docetaxel—skin cancer	0.000535	0.0034	CcSEcCtD
Prasugrel—Thrombocytopenia—Temozolomide—skin cancer	0.000532	0.00338	CcSEcCtD
Prasugrel—Skin disorder—Temozolomide—skin cancer	0.000528	0.00336	CcSEcCtD
Prasugrel—Fatigue—Dactinomycin—skin cancer	0.000518	0.00329	CcSEcCtD
Prasugrel—Haemoglobin—Docetaxel—skin cancer	0.000512	0.00325	CcSEcCtD
Prasugrel—Body temperature increased—Bleomycin—skin cancer	0.00051	0.00324	CcSEcCtD
Prasugrel—Haemorrhage—Docetaxel—skin cancer	0.000509	0.00324	CcSEcCtD
Prasugrel—Urinary tract disorder—Docetaxel—skin cancer	0.000503	0.0032	CcSEcCtD
Prasugrel—Oedema peripheral—Docetaxel—skin cancer	0.000501	0.00319	CcSEcCtD
Prasugrel—Anaphylactic shock—Fluorouracil—skin cancer	0.000501	0.00318	CcSEcCtD
Prasugrel—Urethral disorder—Docetaxel—skin cancer	0.000499	0.00317	CcSEcCtD
Prasugrel—Thrombocytopenia—Fluorouracil—skin cancer	0.000491	0.00312	CcSEcCtD
Prasugrel—Dyspnoea—Temozolomide—skin cancer	0.000485	0.00308	CcSEcCtD
Prasugrel—Eye disorder—Docetaxel—skin cancer	0.000476	0.00302	CcSEcCtD
Prasugrel—Body temperature increased—Dactinomycin—skin cancer	0.000475	0.00302	CcSEcCtD
Prasugrel—Hypersensitivity—Bleomycin—skin cancer	0.000475	0.00302	CcSEcCtD
Prasugrel—Gastrointestinal disorder—Temozolomide—skin cancer	0.000469	0.00298	CcSEcCtD
Prasugrel—Fatigue—Temozolomide—skin cancer	0.000469	0.00298	CcSEcCtD
Prasugrel—Hypotension—Fluorouracil—skin cancer	0.000468	0.00298	CcSEcCtD
Prasugrel—Asthenia—Bleomycin—skin cancer	0.000463	0.00294	CcSEcCtD
Prasugrel—Angiopathy—Docetaxel—skin cancer	0.000462	0.00294	CcSEcCtD
Prasugrel—Immune system disorder—Docetaxel—skin cancer	0.00046	0.00292	CcSEcCtD
Prasugrel—Mediastinal disorder—Docetaxel—skin cancer	0.000459	0.00292	CcSEcCtD
Prasugrel—Dyspnoea—Fluorouracil—skin cancer	0.000447	0.00284	CcSEcCtD
Prasugrel—Hypersensitivity—Dactinomycin—skin cancer	0.000443	0.00282	CcSEcCtD
Prasugrel—Gastrointestinal disorder—Fluorouracil—skin cancer	0.000433	0.00275	CcSEcCtD
Prasugrel—Asthenia—Dactinomycin—skin cancer	0.000431	0.00274	CcSEcCtD
Prasugrel—Body temperature increased—Temozolomide—skin cancer	0.00043	0.00273	CcSEcCtD
Prasugrel—Back pain—Docetaxel—skin cancer	0.000429	0.00272	CcSEcCtD
Prasugrel—Diarrhoea—Dactinomycin—skin cancer	0.000411	0.00261	CcSEcCtD
Prasugrel—Anaemia—Docetaxel—skin cancer	0.00041	0.0026	CcSEcCtD
Prasugrel—Rash—Bleomycin—skin cancer	0.000406	0.00258	CcSEcCtD
Prasugrel—Dermatitis—Bleomycin—skin cancer	0.000406	0.00258	CcSEcCtD
Prasugrel—Hypersensitivity—Temozolomide—skin cancer	0.000401	0.00255	CcSEcCtD
Prasugrel—Leukopenia—Docetaxel—skin cancer	0.000397	0.00252	CcSEcCtD
Prasugrel—Body temperature increased—Fluorouracil—skin cancer	0.000396	0.00252	CcSEcCtD
Prasugrel—Asthenia—Temozolomide—skin cancer	0.00039	0.00248	CcSEcCtD
Prasugrel—Cough—Docetaxel—skin cancer	0.000387	0.00246	CcSEcCtD
Prasugrel—Nausea—Bleomycin—skin cancer	0.000383	0.00243	CcSEcCtD
Prasugrel—Hypertension—Docetaxel—skin cancer	0.000383	0.00243	CcSEcCtD
Prasugrel—Rash—Dactinomycin—skin cancer	0.000379	0.00241	CcSEcCtD
Prasugrel—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—skin cancer	0.000375	0.00238	CcSEcCtD
Prasugrel—Diarrhoea—Temozolomide—skin cancer	0.000372	0.00236	CcSEcCtD
Prasugrel—Hypersensitivity—Fluorouracil—skin cancer	0.000369	0.00235	CcSEcCtD
Prasugrel—Anaphylactic shock—Docetaxel—skin cancer	0.000362	0.0023	CcSEcCtD
Prasugrel—Dizziness—Temozolomide—skin cancer	0.00036	0.00229	CcSEcCtD
Prasugrel—Nausea—Dactinomycin—skin cancer	0.000357	0.00227	CcSEcCtD
Prasugrel—Thrombocytopenia—Docetaxel—skin cancer	0.000354	0.00225	CcSEcCtD
Prasugrel—Skin disorder—Docetaxel—skin cancer	0.000351	0.00223	CcSEcCtD
Prasugrel—Rash—Temozolomide—skin cancer	0.000343	0.00218	CcSEcCtD
Prasugrel—Diarrhoea—Fluorouracil—skin cancer	0.000343	0.00218	CcSEcCtD
Prasugrel—Dermatitis—Temozolomide—skin cancer	0.000343	0.00218	CcSEcCtD
Prasugrel—Headache—Temozolomide—skin cancer	0.000341	0.00217	CcSEcCtD
Prasugrel—Hypotension—Docetaxel—skin cancer	0.000338	0.00215	CcSEcCtD
Prasugrel—Dizziness—Fluorouracil—skin cancer	0.000331	0.00211	CcSEcCtD
Prasugrel—Nausea—Temozolomide—skin cancer	0.000323	0.00205	CcSEcCtD
Prasugrel—Dyspnoea—Docetaxel—skin cancer	0.000322	0.00205	CcSEcCtD
Prasugrel—Rash—Fluorouracil—skin cancer	0.000316	0.00201	CcSEcCtD
Prasugrel—Dermatitis—Fluorouracil—skin cancer	0.000316	0.00201	CcSEcCtD
Prasugrel—Headache—Fluorouracil—skin cancer	0.000314	0.002	CcSEcCtD
Prasugrel—Gastrointestinal disorder—Docetaxel—skin cancer	0.000312	0.00198	CcSEcCtD
Prasugrel—Fatigue—Docetaxel—skin cancer	0.000312	0.00198	CcSEcCtD
Prasugrel—Nausea—Fluorouracil—skin cancer	0.000298	0.00189	CcSEcCtD
Prasugrel—Body temperature increased—Docetaxel—skin cancer	0.000286	0.00182	CcSEcCtD
Prasugrel—Hypersensitivity—Docetaxel—skin cancer	0.000266	0.00169	CcSEcCtD
Prasugrel—Asthenia—Docetaxel—skin cancer	0.000259	0.00165	CcSEcCtD
Prasugrel—Diarrhoea—Docetaxel—skin cancer	0.000247	0.00157	CcSEcCtD
Prasugrel—Dizziness—Docetaxel—skin cancer	0.000239	0.00152	CcSEcCtD
Prasugrel—Rash—Docetaxel—skin cancer	0.000228	0.00145	CcSEcCtD
Prasugrel—Dermatitis—Docetaxel—skin cancer	0.000228	0.00145	CcSEcCtD
Prasugrel—Headache—Docetaxel—skin cancer	0.000227	0.00144	CcSEcCtD
Prasugrel—Nausea—Docetaxel—skin cancer	0.000215	0.00137	CcSEcCtD
